HI
BMY icon

Humankind Investments’s Bristol-Myers Squibb BMY Stock Holding History

Humankind Investments’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.76M Hold
100,000
– – 2.76% 12
2026
Q1 		$6.07M Buy
+100,000
New +$5.83M 3.46% 12
2025
Q4 		– Sell
-32,853
Closed -$1.48M – 41
2025
Q3 		$1.48M Buy
32,853
+247
+0.8% +$11.5K 0.34% 39
2025
Q2 		$1.51M Buy
32,606
+6,632
+26% +$326K 0.37% 39
2025
Q1 		$1.58M Buy
25,974
+823
+3% +$48K 0.41% 37
2024
Q4 		$1.42M Sell
25,151
-2,297
-8% -$128K 0.36% 37
2024
Q3 		$1.42M Sell
27,448
-1,722
-6% -$80.8K 0.51% 36
2024
Q2 		$1.21M Buy
29,170
+1,431
+5% +$64K 0.32% 48
2024
Q1 		$1.5M Buy
27,739
+3,093
+13% +$158K 0.4% 36
2023
Q4 		$1.26M Buy
24,646
+4,403
+22% +$231K 0.38% 37
2023
Q3 		$1.17M Buy
20,243
+991
+5% +$60.7K 0.49% 28
2023
Q2 		$1.23M Sell
19,252
-8,695
-31% -$583K 0.48% 28
2023
Q1 		$1.94M Buy
27,947
+2,371
+9% +$167K 0.8% 19
2022
Q4 		$1.84M Sell
25,576
-747
-3% -$56.3K 0.8% 21
2022
Q3 		$1.87M Buy
26,323
+4,760
+22% +$345K 0.9% 19
2022
Q2 		$1.66M Sell
21,563
-624
-3% -$47.5K 0.79% 20
2022
Q1 		$1.62M Sell
22,187
-2,556
-10% -$172K 0.66% 23
2021
Q4 		$1.54M Buy
24,743
+6,071
+33% +$356K 0.62% 23
2021
Q3 		$1.1M Buy
18,672
+1,441
+8% +$94.9K 0.5% 27
2021
Q2 		$1.15M Buy
17,231
+6,243
+57% +$407K 0.54% 24
2021
Q1 		$694K Buy
+10,988
New +$684K 0.4% 27

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Humankind Investments's BMY Position: Q2 2026 in Review

Humankind Investments held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 100,000 shares worth $5.76M. The position accounts for 2.76% of the portfolio, ranked #12.

Humankind Investments first reported a position in BMY in Q1 2021 and has held it in 21 quarters since. The position peaked at $6.07M in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Humankind Investments held 100,000 shares of Bristol-Myers Squibb worth $5.76M as of Q2 2026.
  • Humankind Investments left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 2.76% of Humankind Investments's portfolio in Q2 2026, its #12 holding.
  • Humankind Investments first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 21 quarters since.
  • Humankind Investments's Bristol-Myers Squibb position peaked at $6.07M in Q1 2026.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Humankind Investments's 13F filing for Q2 2026, filed 14 Aug 2026.